{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:49:47Z","timestamp":1776847787037,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41390-025-04379-1","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T13:13:31Z","timestamp":1758201211000},"page":"1429-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A pilot study of ultra-low-dose chest CT combined with co-production in cystic fibrosis care"],"prefix":"10.1038","volume":"99","author":[{"given":"Richard","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"4379_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jcf.2020.11.008","volume":"20","author":"JS Guimbellot","year":"2021","unstructured":"Guimbellot, J. S. et al. Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation. J. Cyst. Fibros. 20, 213\u2013219 (2021).","journal-title":"J. Cyst. Fibros."},{"key":"4379_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100690","volume":"32","author":"S Sutharsan","year":"2023","unstructured":"Sutharsan, S. et al. Impact of elexacaftor\/tezacaftor\/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry. Lancet Reg. Health Eur. 32, 100690 (2023).","journal-title":"Lancet Reg. Health Eur."},{"key":"4379_CR3","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","volume":"394","author":"HGM Heijerman","year":"2019","unstructured":"Heijerman, H. G. M. et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Lancet 394, 1940\u20131948 (2019).","journal-title":"Lancet"},{"key":"4379_CR4","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","volume":"381","author":"PG Middleton","year":"2019","unstructured":"Middleton, P. G. et al. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N. Engl. J. Med. 381, 1809\u20131819 (2019).","journal-title":"N. Engl. J. Med."},{"key":"4379_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","volume":"205","author":"DP Nichols","year":"2022","unstructured":"Nichols, D. P. et al. Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial. Am. J. Respir. Crit. Care Med. 205, 529\u2013539 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"4379_CR6","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1513\/AnnalsATS.202401-030RL","volume":"21","author":"K Yaacoby-Bianu","year":"2024","unstructured":"Yaacoby-Bianu, K. et al. Effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis with mildly decreased and normal lung function: a real-life observational study. Ann. Am. Thorac. Soc. 21, 1620\u20131623 (2024).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"4379_CR7","doi-asserted-by":"publisher","unstructured":"Reamer, C., O\u2019Malley, C., Nufer, J. & Savant, A. Improved outcomes in cystic fibrosis using modified Re-Education of Airway Clearance Technique (REACT) programme. BMJ Open Qual. 9. https:\/\/doi.org\/10.1136\/bmjoq-2019-000890 (2020).","DOI":"10.1136\/bmjoq-2019-000890"},{"key":"4379_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S2213-2600(22)00434-9","volume":"11","author":"N Mayer-Hamblett","year":"2023","unstructured":"Mayer-Hamblett, N. et al. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Lancet Respir. Med. 11, 329\u2013340 (2023).","journal-title":"Lancet Respir. Med."},{"key":"4379_CR9","first-page":"550","volume":"36","author":"S Diederich","year":"1996","unstructured":"Diederich, S., Roos, N., Thomas, M. & Peters, P. E. Diagnostic imaging in bronchiectases. Value of CT and HRCT]. Radiology 36, 550\u2013559 (1996).","journal-title":"Radiology"},{"key":"4379_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0033-8389(05)70009-9","volume":"36","author":"DM Hansell","year":"1998","unstructured":"Hansell, D. M. Bronchiectasis. Radio. Clin. North Am. 36, 107\u2013128 (1998).","journal-title":"Radio. Clin. North Am."},{"key":"4379_CR11","unstructured":"C., M. et al. The Measurement, Reporting, and Management of Radiation Dose in CT, https:\/\/www.aapm.org\/pubs\/reports\/rpt_96.pdf (2008)."},{"key":"4379_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1148\/radiol.2532090306","volume":"253","author":"M Loeve","year":"2009","unstructured":"Loeve, M. et al. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease? Radiology 253, 223\u2013229 (2009).","journal-title":"Radiology"},{"key":"4379_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10140-017-1487-5","volume":"24","author":"JE Villanueva-Meyer","year":"2017","unstructured":"Villanueva-Meyer, J. E. et al. Pediatric chest CT at chest radiograph doses: when is the ultralow-dose chest CT clinically appropriate? Emerg. Radio. 24, 369\u2013376 (2017).","journal-title":"Emerg. Radio."},{"key":"4379_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4187\/respcare.06436","volume":"64","author":"GR Oates","year":"2019","unstructured":"Oates, G. R. et al. Objective versus self-reported adherence to airway clearance therapy in cystic fibrosis. Respir. Care 64, 176\u2013181 (2019).","journal-title":"Respir. Care"},{"key":"4379_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-2-12","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson, M. J. et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual. Life Outcomes 2, 12 (2004).","journal-title":"Health Qual. Life Outcomes"},{"key":"4379_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky, D. E., Green, L. W. & Levine, D. M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care 24, 67\u201374 (1986).","journal-title":"Med. Care"},{"key":"4379_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jsat.2017.04.001","volume":"77","author":"A Zweben","year":"2017","unstructured":"Zweben, A., Piepmeier, M. E., Fucito, L. & O\u2019Malley, S. S. The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial. J. Subst. Abus. Treat. 77, 72\u201378 (2017).","journal-title":"J. Subst. Abus. Treat."},{"key":"4379_CR18","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/sim.4780132309","volume":"13","author":"MA Birkett","year":"1994","unstructured":"Birkett, M. A. & Day, S. J. Internal pilot studies for estimating sample size. Stat. Med. 13, 2455\u20132463 (1994).","journal-title":"Stat. Med."},{"key":"4379_CR19","doi-asserted-by":"publisher","unstructured":"Stanojevic, S. et al. ERS\/ATS technical standard on interpretive strategies for routine lung function tests. Eur. Respir. J. 2101499. https:\/\/doi.org\/10.1183\/13993003.01499-2021 (2021).","DOI":"10.1183\/13993003.01499-2021"},{"key":"4379_CR20","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","volume":"368","author":"PD Sly","year":"2013","unstructured":"Sly, P. D. et al. Risk factors for bronchiectasis in children with cystic fibrosis. N. Engl. J. Med. 368, 1963\u20131970 (2013).","journal-title":"N. Engl. J. Med."},{"key":"4379_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ppul.25712","volume":"57","author":"D Caudri","year":"2022","unstructured":"Caudri, D. et al. A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis. Pediatr. Pulmonol. 57, 122\u2013131 (2022).","journal-title":"Pediatr. Pulmonol."},{"key":"4379_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1440-1843.2010.01765.x","volume":"15","author":"N Pillarisetti","year":"2010","unstructured":"Pillarisetti, N., Linnane, B., Ranganathan, S. & Arest, C. F. Early bronchiectasis in cystic fibrosis detected by surveillance CT. Respirology 15, 1009\u20131011 (2010).","journal-title":"Respirology"},{"key":"4379_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1136\/thx.2005.045146","volume":"61","author":"PA de Jong","year":"2006","unstructured":"de Jong, P. A. et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 61, 80\u201385 (2006).","journal-title":"Thorax"},{"key":"4379_CR24","doi-asserted-by":"publisher","unstructured":"Lahiri, T. et al. Clinical practice guidelines from the cystic fibrosis foundation for preschoolers with cystic fibrosis. Pediatrics 137. https:\/\/doi.org\/10.1542\/peds.2015-1784 (2016).","DOI":"10.1542\/peds.2015-1784"},{"key":"4379_CR25","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1378\/chest.125.1_suppl.1S","volume":"125","author":"JR Yankaskas","year":"2004","unstructured":"Yankaskas, J. R., Marshall, B. C., Sufian, B., Simon, R. H. & Rodman, D. Cystic fibrosis adult care: consensus conference report. Chest 125, 1S\u201339S (2004).","journal-title":"Chest"},{"key":"4379_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/rccm.200505-810OC","volume":"173","author":"PA de Jong","year":"2006","unstructured":"de Jong, P. A. et al. Estimation of cancer mortality associated with repetitive computed tomography scanning. Am. J. Respir. Crit. Care Med. 173, 199\u2013203 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"4379_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00247-006-0264-5","volume":"36","author":"PA de Jong","year":"2006","unstructured":"de Jong, P. A., Long, F. R. & Nakano, Y. Computed tomography dose and variability of airway dimension measurements: how low can we go? Pediatr. Radio. 36, 1043\u20131047 (2006).","journal-title":"Pediatr. Radio."},{"key":"4379_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/MOP.0000000000001286","volume":"35","author":"BL Diener","year":"2023","unstructured":"Diener, B. L., Huertero, F., Stables-Carney, T., Hoelzer, M. & Kier, C. A new era in cystic fibrosis care: always changing and adapting. Curr. Opin. Pediatr. 35, 603\u2013610 (2023).","journal-title":"Curr. Opin. Pediatr."},{"key":"4379_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcf.2008.09.007","volume":"8","author":"GS Sawicki","year":"2009","unstructured":"Sawicki, G. S., Sellers, D. E. & Robinson, W. M. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J. Cyst. Fibros. 8, 91\u201396 (2009).","journal-title":"J. Cyst. Fibros."},{"key":"4379_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jcf.2025.02.016","volume":"24","author":"RS Everhart","year":"2025","unstructured":"Everhart, R. S. et al. Mental health and adherence in CF: self-efficacy and perceived barriers as mediators. J. Cyst. Fibros. 24, 334\u2013340 (2025).","journal-title":"J. Cyst. Fibros."},{"key":"4379_CR31","first-page":"117","volume":"7","author":"LC Bishay","year":"2016","unstructured":"Bishay, L. C. & Sawicki, G. S. Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis. Adolesc. Health Med Ther. 7, 117\u2013124 (2016).","journal-title":"Adolesc. Health Med Ther."},{"key":"4379_CR32","doi-asserted-by":"publisher","first-page":"107555","DOI":"10.1016\/j.rmed.2024.107555","volume":"223","author":"A Basavaraj","year":"2024","unstructured":"Basavaraj, A. et al. Severity of bronchiectasis predicts use of and adherence to high frequency chest wall oscillation therapy - Analysis from the United States Bronchiectasis and NTM research registry. Respir. Med. 223, 107555 (2024).","journal-title":"Respir. Med."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04379-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04379-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04379-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:51:48Z","timestamp":1776844308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04379-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4379"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04379-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants in this study provided written informed consent prior to enrollment. For subjects under 18 years of age, written informed consent was obtained from a parent or legal guardian and assent was obtained from the minor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent Statement"}}]}}